M&A Deal Summary

Takeda Acquires Nycomed Pharma AG

On May 19, 2011, Takeda acquired life science company Nycomed Pharma AG from Avista Healthcare Partners, Nordic Capital, HarbourVest Partners, Stockwell Capital and aPriori Capital Partners for 9.6B EUR

Acquisition Highlights
  • This is Takeda’s 4th transaction in the Life Science sector.
  • This is Takeda’s 2nd largest (disclosed) transaction.
  • This is Takeda’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2011-05-19
Target Nycomed Pharma AG
Sector Life Science
Buyer(s) Takeda
Sellers(s) Avista Healthcare Partners
Nordic Capital
HarbourVest Partners
Stockwell Capital
aPriori Capital Partners
Deal Type Add-on Acquisition
Deal Value 9.6B EUR

Target

Nycomed Pharma AG

Zurich, Switzerland
Nycomed Pharma AG is a manufacturer, marketer, and promoting a range of Rx and OTC pharmaceutical products in Europe. Nycomed offers hospital products and general practitioner medicines, as well as provides late-stage clinical development, and registration and marketing. Nycomed Pharma AG was established in 1986 and is based in Zurich, Switzerland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Takeda

Tokyo, Japan
Category Company
Founded 1781
Sector Life Science
Employees47,347
Revenue 4.03T JPY (2023)
DESCRIPTION
Takeda's corporate headquarters in Tokyo, Japan.
Takeda's corporate headquarters in Tokyo, Japan.

Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was originally established in 1781 and is based in Tokyo, Japan.

DEAL STATS #
Overall 4 of 18
Sector (Life Science) 4 of 17
Type (Add-on Acquisition) 4 of 15
Country (Switzerland) 1 of 1
Year (2011) 1 of 2
Size (of disclosed) 2 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-13 Millennium Pharmaceuticals

Cambridge, Massachusetts, United States

Millennium Pharmaceuticals, Inc. is a biopharmaceutical company. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates.

Buy $8.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-21 Intellikine

La Jolla, California, United States

Intellikine, Inc. is a private company focused on the development of innovative, small molecule drugs targeting the PI3K/mTOR pathway for the treatment of cancer and other serious diseases.

Buy $190M

Seller(S) 5

SELLER

Avista Healthcare Partners

New York, New York, United States
Category Private Equity Firm
Founded 2005
PE ASSETS 8.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 7 of 30
Sector (Life Science) 1 of 7
Type (Add-on Acquisition) 3 of 15
Country (Switzerland) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-12 Appalachian Midstream Partners

Columbus, Ohio, United States

Appalachian Midstream Partners’ primary asset is a 23 mile 24” natural gas fuel line which connects multiple interstate pipelines to an industrial development outside Toledo, Ohio. AMP also owns and operates a 56-mile pipeline and right-of-way that provides access to the Leidy Storage field and multiple major interstate pipelines in north-central Pennsylvania located in the Marcellus Shale fairway. Appalachian Midstream Partners is based in Columbus, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-13 Sidewinder Drilling

Houston, Texas, United States

Sidewinder is a land-based drilling contractor that utilizes a technologically advanced fleet of highly mobile, operationally flexible, ultra-efficient land drilling rigs to service exploration and production companies. Sidewinder Drilling was founded in 2011 and is based in Houston, Texas.

Buy -
SELLER

Nordic Capital

Stockholm, Sweden

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1989
PE ASSETS 31.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Nordic Capital is a private equity investment firm that targets mid to large-sized company investments located in Northern Europe as well as the US. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and is based in Stockholm, Sweden.

DEAL STATS #
Overall 31 of 79
Sector (Life Science) 3 of 6
Type (Add-on Acquisition) 13 of 24
Country (Switzerland) 3 of 4
Year (2011) 2 of 5
Size (of disclosed) 1 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-28 Falck

Copenhagen, Denmark

Falck is a provider of rescue and safety courses. Falck’s activities are directed at preventing accidents and disease; providing assistance in situations of emergency, accidents and need; and helping people move on with their lives after illness or accidents. Falck was founded in 1906 and is based in Copenhagen, Denmark.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-20 Bulten

Gothenburg, Sweden

Bulten is a provider of fasteners to the European automotive industry. The company’s product range includes everything from customer-specific standard products to specialist, customized fasteners. The company also provides technical development, line-feeding, logistics, material, and production expertise. Bulten was founded in 1873 and is based in Gothenburg, Sweden.

Sell -
SELLER

HarbourVest Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1978
PE ASSETS 86.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

HarbourVest Partners, LLC is an investment firm that makes investments in new private equity partnerships, acquires secondary interests, and makes direct investments in operating companies. HarbourVest's largest investment area is investments in private equity funds, comprising of approximately 2/3 of HarbourVest's assets. HarbourVest's direct investment group looks for investments in growth oriented businesses at a variety of stages. The Group generally targets co-investments of $5 to $100 million, growth capital financings of $5 to $40 million, or mezzanine commitments of $5 to $20 million. Sectors of interest include software, hardware, data communications, telecommunications, and financial services. HarbourVest was formed in 1997 to assume the business of Hancock Venture Partners which was formed in 1982. HarbourVest Partners is based in Boston, Massachusetts, with additional offices in London, Tokyo, and Hong Kong.

DEAL STATS #
Overall 24 of 132
Sector (Life Science) 2 of 5
Type (Add-on Acquisition) 7 of 57
Country (Switzerland) 1 of 2
Year (2011) 3 of 8
Size (of disclosed) 2 of 39
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-19 Roompot

Goes, Netherlands

Roompot is a holiday park operator active in the exploitation of holiday parks, tour operating services for third party holiday parks, and the development of holiday parks. Roompot was founded in 1965 and is based in Goes, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-26 FreeScale Semiconductor

Austin, Texas, United States

Freescale Semiconductor, Inc. is a designer and manufacturer of embedded semiconductors for the automotive, consumer, industrial, networking and wireless markets. FreeScale designs, researches and development, manufacturing or sales operations in more than 30 countries.

Sell -
SELLER

Stockwell Capital

Austin, Texas, United States

Investor Investor

Category Private Equity Firm
Founded 2002
PE ASSETS 750M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Stockwell Capital is a co-investment firm, focused on making minority investments alongside private equity sponsors. Stockwell is a generalist investor, with no sector preferences and looks to commit $3 to $10 million per investment. The Firm will consider opportunities throughout the US and Europe and prefers late-stage or growth equity situations. Stockwell Capital was formed in 2002 and is based in Chicago.

DEAL STATS #
Overall 10 of 41
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 3 of 12
Country (Switzerland) 1 of 1
Year (2011) 3 of 4
Size (of disclosed) 1 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-04 Neurotherm

Wilmington, Massachusetts, United States

NeuroTherm, is a developer, manufacturer and provider of medical products used in interventional pain management. NeuroTherm’s products include radiofrequency (“RF”) generators and related consumable products as well as epidural catheters, discography devices, intradiscal therapies, pharmaceutical compounding and procedure tables.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-24 HIT Entertainment

London, United Kingdom

HIT Entertainment is one of the world's leading independent children's entertainment producers and rights-owners. HIT's portfolio includes properties, such as Thomas & Friends™, Barney™, Bob the Builder™, Fireman Sam™, Angelina Ballerina™, Mike the Knight™, Pingu™ and Rainbow Magic™. Launched in 1989, HIT's lines of business span television and video production, content distribution, publishing, consumer products licensing and live events and has operations in the UK, US, Canada, Hong Kong and Japan.

Sell $680M
SELLER

aPriori Capital Partners

Investor Investor Investor

Category Private Equity Firm
Founded 1985
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

aPriori Capital Partners (formerly DLJ Merchant Banking Partners) is a middle-market private equity firm focused on middle-market buyouts in the US and Europe. Sectors of interest include healthcare, retail, consumer, energy, business services, and industrial. aPriori was originally established in 1985 and has offices in New York and Los Angeles.

DEAL STATS #
Overall 32 of 51
Sector (Life Science) 7 of 9
Type (Add-on Acquisition) 14 of 22
Country (Switzerland) 3 of 3
Year (2011) 2 of 4
Size (of disclosed) 1 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-17 NextPharma Technologies

London, United Kingdom

NextPharma Technologies is a pharmaceutical contract development and manufacturing organization serving worldwide markets. NextPharma provides a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, clinical trial services, analytical services, commercial manufacturing and packaging, generic dossiers, and licensing. NextPharma Technologies was founded in 2000 and is based in London, United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-01 Enduring Resources II

Denver, Colorado, United States

Enduring Resources II LLC is focused on pursuing a diverse portfolio of acquisition and exploitation opportunities in central onshore U.S. basins. Enduring Resources II was founded in 2011 and is based in Denver, Colorado.

Buy -
Mergr

Product

Company

Legal